Navigation Links
NeoStem Expands Stem Cell Collection Center Network Into New Jersey Led by Leading Plastic Surgeon and Anti-Aging Authority
Date:3/19/2009

s to donate and store their own stem cells when they are young and healthy, for personal use years or decades later in times of medical need. The Company's stem cell collection center model generates revenue for the Company through ongoing fees derived from stem cell collections and processing and fees charged to the centers for marketing and support. Long-term storage generates further revenue on a recurring basis.

Robin Smith, MD, CEO of NeoStem, said, "We are extremely pleased to have Dr. Giampapa's Institute join our network of collection centers. He is at the forefront of developing innovative stem cell therapies addressing anti-aging and regenerative medicine, an important arena for NeoStem. His prestige internationally as well as in the U.S. will draw clients from around the world, especially China, through NeoStem's relationships there. We look forward to a fruitful partnership with him on many fronts."

About NeoStem, Inc.

NeoStem is developing a network of adult stem cell collection centers that are focused on enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times for future medical need. The Company has also entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells.

In November 2008, NeoStem signed a definitive agreement to merge China Biopharmaceuticals Holdings, Inc. (OTCBB: CHBP), a Chinese pharmaceutical company with and into the Company's wholly-owned subsidiary. CHBP holds a 51% interest in Suzhou Erye Pharmaceutical Co. Ltd. ("Erye"). For the nine months ended September 30, 2008 CHBP reported revenues of $37 million representing an increase of 64% over the comparable p
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies
2. NeoStem Receives Notice of Noncompliance from NYSE Alternext US
3. NeoStems New York City Adult Stem Cell Collection Center Has Opened and Begun Collections
4. NeoStem Completes $500,000 Private Placement With Strategic Investor
5. NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia
6. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
7. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
8. NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
9. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
10. Suzanne Somers To Promote Growing Importance of Storing Your Own Adult Stem Cells Under Alliance With NeoStem, Inc.
11. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Communications, a leading provider of strategic communications services to corporations and ... the United States and Europe ... JD, is returning to the firm,s Washington, D.C. ... more than two years of service as Associate Commissioner for the ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo announced ... from the National Institutes of Health (NIH) to help ... effective treatments to patients on a faster timeline. Organovo ... Sciences (NCATS) and the National Eye Institute (NEI) to ...
(Date:1/14/2014)... MD (PRWEB) January 14, 2014 ... to developing innovative information technology solutions for patients, ... health care stakeholders, announced today the signing of ... US Food and Drug Administration (FDA). This ...
(Date:1/14/2014)... During the 1600’s through the 1800’s doctors contributed unknowingly ... this time period, doctors did not know that they needed ... death of vulnerable patients. In the same way, medical interns ... unwittingly transmitting herpes viruses to their patients. The CBCD explains. ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... , LONDON, Sept. 8 ... services to pharmaceutical and biotechnology companies, is pleased to announce ... office. Walter Colasante, as a Vice President, and Sophie ... and reimbursement expertise and expand its current offerings. , ...
... Sept. 8 PDL BioPharma, Inc. (PDL) (Nasdaq: ... ended September 30, 2009 of approximately $71 million, as compared ... revenues are based on second quarter product sales by PDL,s ... by MedImmune. When compared with 2008, royalty revenue for foreign ...
... PAREXEL International Corporation (Nasdaq: PRXL ) announced today it ... Boston, MA. Josef von Rickenbach, Chairman and Chief Executive Officer, ... EDT on Friday, September 11, 2009. , , ... "Upcoming Events" section on PAREXEL,s "Investors" homepage at www.PAREXEL.com ...
Cached Biology Technology:PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 2PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million 2PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million 3PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 2
(Date:7/9/2014)... fungal pathogens pose a greater threat to biodiversity ... of amphibians, bats, corals, bees and snakes. New ... in the prestigious journal Nature reveals ... to a deadly chytrid fungus implicated in global ... important because it is the basis of vaccination ...
(Date:7/9/2014)... from The Cancer Genome Atlas (TCGA) Research Network ... pathway in lung adenocarcinoma, the most common subtype ... may expand the number of possible therapeutic targets ... number of patients with treatable mutations because many ... exist. , TCGA is jointly funded and managed ...
(Date:7/9/2014)... be able to cope with the rising salinity of Arctic ... today is best known for its tundra and polar bear ... 38 million years ago during what is known as the ... temperate forest with brackish water, home to a variety of ... giant tortoises. Much of what is known about the region ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3
... of the Lawson Health Research Institute and Professor of ... of Medicine & Dentistry at The University of Western ... biology from rebro University in Sweden. Dr. ... and the only recipient this year in the field ...
... of a seething, breathing microbial world. Microorganisms populate every ... of the human skin, to rainforest floors, to hydrothermal ... powerful and pervasive role of microbes in sustaining life, ... is the subject of The Uncharted Microbial World: Microbes ...
... twins are not genetically identical. This surprising finding ... a study being published today in the prestigious journal ... be of great significance for research on hereditary diseases ... How can it be that one identical twin might ...
Cached Biology News:Unexplored microbes hold incredible potential for science and industry 2Unexplored microbes hold incredible potential for science and industry 3
... is a new product number, created ... If showing no availability yet, please ... (E6152) or contact customer service for ... diam. 11.25 6.40 in. ...
... Analysis of large numbers of samples may ... which requires minimum operator attention. System control ... and interface CE 4900. The elegant, powerful ... Windows XP and Windows 98 and 2000., The ...
Mouse monoclonal antibody to QPCT - glutaminyl-peptide cyclotransferase (glutaminyl cyclase)...
... number is a new ... easily match Cornings product ... availability yet, please order ... number (Z35,347-7) or contact ...
Biology Products: